Major Breakthrough in Life Sciences : Shingles Vaccine is a Step Closer to Approval

As the  recombinant gets approval from an advisory panel of the US Food and Drug Administration (FDA), the medical fraternity celebrated the move towards finding a cure for shingles rash. Shringrix from GlaxoSmithKline (GSK) got clear thumbs up from the Vaccines and Related Biological Products Advisory Committee for being effective and safe for shingles patients…

Read More
Stent angioplasty procedure

The Future of the Vascular Stents Industry Depends on Innovative Technologies and the Persistent Vendor

From what was first introduced as a bailout technique for failed or suboptimal iliac angioplasty to a versatile and valuable instrument for an assortment of primary and adjuvant applications, the technology in vascular stents industry has progressively evolved, thanks to the emergence of coronary and peripheral vascular stents, delivering precision with a range of innovative…

Read More
global cancer gene therapy market

Cancer Gene Therapy : A Ground-Breaking Development in Life Sciences Sector

As the Food and Drug Administration (FDA) panel approved the first-ever gene therapy treatment for cancer, the doors for better treatment of this deadly disease have opened. It’s been a while that researchers have been working on gene therapy to address various kinds of cancer. Approval from FDA has, in fact, encouraged several pharma majors…

Read More
celiac disease

Curing Celiac Disease without Sacrificing Gluten Rich Food

While it is true that no specific drug has been approved for the treatment of Celiac disease, there are some anti-inflammatory and immunosuppressant medications and nutritional supplements that are consumed as off-label therapy in celiac disease. Celiac disease is an autoimmune inflammatory disease of the small intestine, which is triggered by intake of gluten from…

Read More